Pharmacy procedures, page 1 of 5

Aborifacient agent therapy

The use of an agent or drug to interupt pregnancy after implantation. This page describes aborifacient agent therapy and where it is available across Weyland-Yutani Health System.

As a treatment, aborifacient agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• treatment with abortifacient

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0010126 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › reproductive control agent therapy.

Specialty: Pharmacy

Broader services

• pharmacotherapy

Used to treat

• xanthinuria
• hypogonadotropic hypogonadism 19 with or without anosmia
• Usher syndrome type 1E
• Raynaud disease
• allescheriosis

Showing 5 of 9.

Preparing for your visit

Ask your clinician whether you need to fast, adjust medications or arrange a ride home before aborifacient agent therapy.

Available at

• Ashland Riverside Outpatient Center
• Grants Pass Valley Outpatient Center

Providers offering this service

• Dr. Maria Peterson, MD
• Dr. Nadia Lewis, DO
• Dr. Laura Tran, MD
• Dr. Diego Huang, MD
• Dr. Chen Sanchez, DO

Showing 5 of 8.

Related articles

• What to Expect: Aborifacient agent therapy

Reference links

• http://purl.obolibrary.org/obo/MAXO_0010126

Abuse deterrent agent therapy

About this service. Medication given to prevent or deter a patient from using a substance.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• abuse deterrent drug treatment

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000218 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › therapeutic antidotes, deterrents, and toxicologic agent therapy.

Specialty: Pharmacy

Broader services

• therapeutic antidotes, deterrents, and toxicologic agent therapy

More specific services

• smoking cessation agent therapy

Used to treat

• sickle cell disease
• retinitis pigmentosa 19
• retinitis pigmentosa 36
• primary ciliary dyskinesia 24
• Lenz-Majewski hyperostotic dwarfism

Showing 5 of 12.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Available at

• Lake Oswego Parkside Specialty Clinic

Providers offering this service

• Dr. Alice Harris, MD
• Oscar Burke, NP
• Dr. Emily Ellis, MD
• Dr. Rosa Cruz, DO
• Dr. Kenji Lin, MD

Showing 5 of 10.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000218

ACE2 inhibitor therapy

Use of a drug that inhibits angiotensin-converting enzyme (ACE) 2, an enzyme that catalyzes the conversion of angiotensin I to angiotensin II. Weyland-Yutani Health System offers ACE2 inhibitor therapy through Pharmacy.

As a treatment, ACE2 inhibitor therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• angiotensin-converting enzyme-2 inhibitor therapy
• Treatment with ACE-2 inhibitor
• treatment with EC 3.4.17.23 (angiotensin-converting enzyme 2) inhibitor
• treatment with hACE2 inhibitor

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000656 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › molecular pathway modifying agent therapy › enzyme inhibitor agent therapy.

Specialty: Pharmacy

Broader services

• molecular pathway modifying agent therapy
• vasodilator agent therapy
• cardiovascular agent therapy

Used to treat

• reticulate acropigmentation of Kitamura
• orofaciodigital syndrome IX
• Brugada syndrome 5
• Jackson-Weiss syndrome
• pleural tuberculosis

Showing 5 of 9.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Longview Fairview Outpatient Center

Providers offering this service

• Dr. Lakshmi Wong, MD
• Dr. Brandon Edwards, MD
• Dr. Brandon Gomez, DO
• Dr. Wei Diaz, MD
• Dr. Sofia Aguilar, DO

Showing 5 of 13.

Related articles

• Is ACE2 inhibitor therapy Right for You?
• Questions to Ask About ACE2 inhibitor therapy

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000656

ADHD agent therapy

Use of medication for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). This page describes ADHD agent therapy and where it is available across Weyland-Yutani Health System.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• ADHD drug therapy
• ADHD drug treatment
• Attention Deficit Hyperactivity Disorder drug therapy
• Attention Deficit Hyperactivity Disorder drug treatment
• drug therapy for ADHD

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000437 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › central nervous system agent therapy.

Specialty: Pharmacy

Broader services

• pharmacotherapy

Used to treat

• Aicardi-Goutieres syndrome
• Clostridium difficile colitis
• immunoglobulin light chain amyloidosis
• autosomal recessive nonsyndromic deafness 98
• neonatal diabetes mellitus

Showing 5 of 8.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Available at

• Portland Westside Clinic

Providers offering this service

• Dr. Anika Davis, MD
• Rachel Doan, NP
• Dr. Ravi Yamamoto, MD
• Dr. Adrian Chang, MD
• Dr. Maria Reed, MD

Showing 5 of 9.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000437

Adrenergic drug therapy

Therapy using any agent that acts on an adrenergic receptor or affects adrenergic signal transduction. Weyland-Yutani Health System offers adrenergic drug therapy through Pharmacy.

As a treatment, adrenergic drug therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• adrenergic agent drug treatment
• treatment with adrenergic agent
• treatment with adrenergic drug
• treatment with adrenergic medication

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0001025 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › cardiovascular agent therapy.

Specialty: Pharmacy

Broader services

• cardiovascular agent therapy
• neurotransmitter agent therapy

More specific services

• alpha adrenergic agonist therapy
• beta-adrenergic antagonist therapy
• adrenergic uptake inhibitor agent therapy

Used to treat

• Smith-McCort dysplasia
• ring chromosome 20 syndrome
• amelogenesis imperfecta type 3A
• short-rib thoracic dysplasia 7 with or without polydactyly
• meningoencephalitis

Showing 5 of 14.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Corvallis Valley Clinic
• Canby Eastside Specialty Clinic

Providers offering this service

• Dr. Emily Gomez, DO
• Dr. Darius Aguilar, MD
• Dr. Tamar Hall, DO
• Dr. Elena Hussain, MD
• Dr. Jessica Aguilar, DO

Showing 5 of 12.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0001025
• http://purl.obolibrary.org/obo/NCIT_C29747

Adrenergic uptake inhibitor agent therapy

Any drug or agent that inhibits adrenergic uptake. Weyland-Yutani Health System offers adrenergic uptake inhibitor agent therapy through Pharmacy.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• treatment with adrenergic uptake inhibitor

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0001706 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › cardiovascular agent therapy › adrenergic drug therapy.

Specialty: Pharmacy

Broader services

• adrenergic drug therapy

Used to treat

• spondylometaphyseal dysplasia corner fracture type
• sarcoma
• interval angle-closure glaucoma
• gestational choriocarcinoma
• auditory system disease

Showing 5 of 8.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Available at

• Lake Oswego Parkside Specialty Clinic
• Lake Oswego Riverside Health Center

Providers offering this service

• Liam Tran, NP
• Dr. Caleb Aguilar, MD
• Dr. Xavier Williams, MD
• Dr. Adrian Doan, DO
• Dr. Xavier Shah, MD

Showing 5 of 13.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0001706

Alkylating agent therapy

alkylating agent therapy: An antineoplastic agent that replaces hydrogen atom(s) in nucleophilic moieties with alky radical(s), hindering proper function. Alkylating agents exhibit cytotoxic effects through the alkylation of DNA, resulting in strand cross-linking, ultimately inhibiting DNA replication and cancer cell growth.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• alkylating drug therapy
• anti-neoplastic alkylating agent therapy
• antineoplastic alkylating agent therapy
• treatment with alkylating agent
• treatment with alkylating drug
• treatment with alkylating medication

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000230 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › antineoplastic therapy.

Specialty: Pharmacy

Broader services

• antineoplastic therapy

Used to treat

• multiple types of congenital heart defects 6
• autosomal recessive cutis laxa type II classic type
• COVID-19
• cataract 1 multiple types
• xeroderma pigmentosum group C

Showing 5 of 17.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Providers offering this service

• Dr. Ravi Patel, MD
• Dr. Amara Dang, DO
• Dr. Aaron Obi, MD
• Dr. Elena Bell, MD
• Dr. Adrian Brown, DO

Showing 5 of 11.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000230
• http://purl.obolibrary.org/obo/NCIT_C1590
• http://purl.obolibrary.org/obo/NCIT_C223

Alpha adrenergic agonist therapy

About this service. Treatment with an agent that selectively binds to and activates alpha-adrenergic receptors.

As a treatment, alpha adrenergic agonist therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• a-adrenergic agonist drug treatment
• a-adrenergic agonist therapy
• a-adrenergic receptor agonist therapy
• alpha adrenergic agonist agent drug treatment
• alpha adrenergic agonist drug therapy
• alpha adrenergic agonist treatment
• alpha adrenergic receptor agonist therapy
• alpha adrentergic receptor agonist agent therapy
• alpha-adrenergic receptor agonist drug therapy
• alpha-adrenergic receptor agonist treatment
• alpha-adrenoceptor agonist agent therapy
• alpha-adrenoceptor agonist drug therapy
• alpha-adrenoceptor agonist therapy
• treatment with alpha-adrenergic agonist

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000183 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › cardiovascular agent therapy › adrenergic drug therapy › alpha adrenergic agent therapy.

Specialty: Pharmacy

Broader services

• adrenergic drug therapy

Used to treat

• disease of metabolism
• familial cold autoinflammatory syndrome 4
• autosomal dominant nonsyndromic deafness 16
• Mikulicz disease
• drug dependence

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Lake Oswego Parkside Specialty Clinic
• Eugene Willow Creek Family Health Clinic

Providers offering this service

• Dr. Nora Chowdhury, DO
• Dr. Michael Banerjee, MD
• Emily Bailey, NP
• Eli Chowdhury, NP
• Dr. Carlos Bui, MD

Showing 5 of 7.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000183

Alpha-glucosidase inhibitor therapy

Treatment with an inhibitor that inteferes with the action of alpha-glucosidase. Our Pharmacy team performs alpha-glucosidase inhibitor therapy and explains each step beforehand.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000904 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › antidiabetic agent therapy.

Specialty: Pharmacy

Broader services

• pharmacotherapy

Used to treat

• popliteal pterygium syndrome
• COVID-19
• retinitis pigmentosa 35
• thalassemia
• retinal vasculitis

Showing 5 of 12.

Preparing for your visit

Ask your clinician whether you need to fast, adjust medications or arrange a ride home before alpha-glucosidase inhibitor therapy.

Available at

• Corvallis Valley Clinic

Providers offering this service

• Dr. Tamar Novak, MD
• Nathan Davis, NP
• Dr. Imani Chen, MD
• Dr. Karen Edwards, MD
• Dr. Dominic Owens, MD

Showing 5 of 8.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000904

Aminoglycoside agent therapy

An antibacterial substance with aminoglycoside structure. Weyland-Yutani Health System offers aminoglycoside agent therapy through Pharmacy.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• aminoglycoside drug therapy
• aminoglycoside drug treatment
• aminoglycosides therapy

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000196 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › anti-infective agent therapy › antimicrobial agent therapy › antibacterial agent therapy.

Specialty: Pharmacy

Broader services

• antibacterial agent therapy

Used to treat

• tongue squamous cell carcinoma
• Renpenning syndrome
• prostate cancer
• urogenital tuberculosis
• clitoris cancer

Showing 5 of 9.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Providers offering this service

• Dominic Lee, NP
• Dr. Nadia Cooper, MD
• Dr. Wei Diaz, MD
• Dr. Jessica Sharma, MD
• Dr. Daniel Nakamura, DO

Showing 5 of 17.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000196

AMPA receptor antagonist therapy

AMPA receptor antagonist therapy: Use of a drug that selectively binds to and inhibits AMPA receptors.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• treatment with AMPA receptor antagonist
• treatment with AMPA receptor blockade
• treatment with AMPA receptor blocker

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000663 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › molecular pathway modifying agent therapy › receptor antagonist therapy.

Specialty: Pharmacy

Broader services

• receptor antagonist therapy
• glutamatergic pathway modifying agent therapy

Used to treat

• seminal vesicle acute gonorrhea
• Dent disease
• infantile hypotonia with psychomotor retardation and characteristic facies-3
• hemophilia
• overactive bladder syndrome

Showing 5 of 9.

Preparing for your visit

Ask your clinician whether you need to fast, adjust medications or arrange a ride home before AMPA receptor antagonist therapy.

Available at

• Lakewood Medical Center
• Medford Stonebridge Health Center

Providers offering this service

• Dr. Fatima Chowdhury, DO
• Ali Hernandez, NP
• Dr. Emma Flores, MD
• Dr. Maya Quinn, DO
• Dr. Samir Andersson, MD

Showing 5 of 10.

Related articles

• AMPA receptor antagonist therapy at Weyland-Yutani Health System

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000663

Anabolic steroid modifying agent therapy

Use of a compound which stimulates anabolism and inhibits catabolism. Anabolic agents stimulate the development of muscle mass, strength, and power. Our Pharmacy team performs anabolic steroid modifying agent therapy and explains each step beforehand.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• anabolic agent therapy
• anabolic steroid modifying drug treatment
• treatment with anabolic steroid

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000285 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › hormone modifying therapy › sex hormone modifying agent therapy.

Specialty: Pharmacy

Broader services

• sex hormone modifying agent therapy

Used to treat

• lissencephaly
• chemical colitis
• thiamine deficiency disease
• Usher syndrome type 3A
• congenital sucrase-isomaltase deficiency

Showing 5 of 14.

Preparing for your visit

Ask your clinician whether you need to fast, adjust medications or arrange a ride home before anabolic steroid modifying agent therapy.

Providers offering this service

• Dr. Amelia Bailey, MD
• Dr. Aisha Morgan, MD
• Dr. Yasmin Adeyemi, MD
• Liam Ramirez, NP
• Dr. Maya Olsen, DO

Showing 5 of 7.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000285

Androgen modifying agent therapy

Treatment with an agent to modify androgen action. Weyland-Yutani Health System offers androgen modifying agent therapy through Pharmacy.

As a treatment, androgen modifying agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• treatment with androgen agent
• treatment with androgen drug
• treatment with androgen medication
• treatment with androgen modifying agent
• treatment with androgen modifying drug

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000286 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › hormone modifying therapy › sex hormone modifying agent therapy.

Specialty: Pharmacy

Broader services

• sex hormone modifying agent therapy

More specific services

• androgen stimulant agent therapy
• androgen suppressant hormone agent therapy

Used to treat

• acrofacial dysostosis, Catania type
• long QT syndrome 14
• mushroom workers' lung
• peripheral vascular disease
• ovarian gonadoblastoma

Showing 5 of 8.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Available at

• Newberg Willow Creek Family Health Clinic
• Canby Parkside Family Health Clinic

Providers offering this service

• Dr. Tomas Gonzalez, MD
• Dr. Uma Hernandez, MD
• Dr. Elena Young, DO
• Dr. Amir Thomas, MD
• Dr. Jonah Kaur, DO

Showing 5 of 9.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000286

Androgen stimulant agent therapy

About this service. Use of a compound which increases or activates the biosynthesis or actions of androgens.

As a treatment, androgen stimulant agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• treatment with androgen agonist
• treatment with androgen stimulant

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000291 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › hormone modifying therapy › sex hormone modifying agent therapy › androgen modifying agent therapy.

Specialty: Pharmacy

Broader services

• androgen modifying agent therapy

Used to treat

• chemical colitis
• acrorenal syndrome
• hypogonadism
• Bardet-Biedl syndrome
• rectum cancer

Showing 5 of 10.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Springfield Lakeview Health Center
• Keizer Meadowbrook Family Health Clinic

Providers offering this service

• Lucas Davis, NP
• Dr. Nathan Walker, MD
• Dr. Arjun Chang, MD
• Brandon Thomas, NP
• Isabella Alvarez, NP

Showing 5 of 10.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000291

Antacid agent therapy

About this service. A therapy used to neutralize stomach acidity.

As a treatment, antacid agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• antacid drug therapy
• antacid medication therapy
• treatment with antacid

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000631 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › gastrointestinal agent therapy.

Specialty: Pharmacy

Broader services

• gastrointestinal agent therapy

Used to treat

• osteogenesis imperfecta type 15
• autosomal dominant nonsyndromic deafness 33
• COACH syndrome
• white piedra
• vulvovaginitis

Showing 5 of 9.

Preparing for your visit

Ask your clinician whether you need to fast, adjust medications or arrange a ride home before antacid agent therapy.

Available at

• Forest Grove Maple Park Family Health Clinic

Providers offering this service

• Dr. Brandon Hall, MD
• Dr. Khalid Foster, MD
• Dr. Tamar Novak, MD
• Dr. Omar Abbott, MD
• Dr. Valeria Hill, MD

Showing 5 of 10.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000631

Anti-HIV agent therapy

Treatment with an antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. This page describes anti-HIV agent therapy and where it is available across Weyland-Yutani Health System.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• anti-HIV drug treatment
• treatment with anti-HIV agent
• treatment with anti-HIV drug
• treatment with anti-human immunodeficiency virus agent
• treatment with anti-human immunodeficiency virus drug
• treatment with anti-human immunodeficiency virus medication

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000248 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › anti-infective agent therapy › antimicrobial agent therapy › antiviral agent therapy.

Specialty: Pharmacy

Broader services

• antiviral agent therapy

More specific services

• non-nucleoside reverse transcriptase inhibitor therapy
• nucleoside and nucleotide reverse transcriptase inhibitor therapy

Used to treat

• xeroderma pigmentosum
• Meckel syndrome
• short-rib thoracic dysplasia 8 with or without polydactyly
• cryptophthalmia
• nephritis

Showing 5 of 10.

Preparing for your visit

Ask your clinician whether you need to fast, adjust medications or arrange a ride home before anti-HIV agent therapy.

Available at

• Ashland Riverside Outpatient Center
• Tualatin Willow Creek Clinic
• Wilsonville Pioneer Square Outpatient Center

Providers offering this service

• Dr. Adam Yamamoto, MD
• Dr. Tamar Novak, MD
• Dr. Jessica Obi, MD
• Dr. Camila Silva, MD
• Dr. Ruth Morales, MD

Showing 5 of 12.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000248
• http://purl.obolibrary.org/obo/NCIT_C1660

Anti-HSV-1 agent therapy

anti-HSV-1 agent therapy: Treatment with an antiviral agent that destroys or inhibits the replication of the herpes simplex virus-1.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• anti-herpes simplex virus 1 drug therapy
• anti-herpes simplex virus 1 medication treatment
• treatment for HSV-1 with medication
• treatment with anti-HSV-1 agent
• treatment with anti-HSV-1 drug
• treatment with anti-HSV-1 medication

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000638 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › anti-infective agent therapy › antimicrobial agent therapy › antiviral agent therapy › antiherpetic agent therapy › anti-HSV agent therapy.

Specialty: Pharmacy

Broader services

• antiherpetic agent therapy

Used to treat

• hypochondriasis
• tricuspid valve insufficiency

Preparing for your visit

Ask your clinician whether you need to fast, adjust medications or arrange a ride home before anti-HSV-1 agent therapy.

Available at

• Canby Parkside Family Health Clinic

Providers offering this service

• Dr. Kevin Harris, MD
• Dr. Ricardo Tanaka, MD
• Dr. Kai Campbell, MD
• Dr. Jasmine Mendoza, DO
• Dr. Amara Choi, MD

Showing 5 of 11.

Related articles

• What to Expect: Anti-HSV-1 agent therapy
• Anti-HSV-1 agent therapy at Weyland-Yutani Health System
• Anti-HSV-1 agent therapy at Weyland-Yutani Health System
• Anti-HSV-1 agent therapy at Weyland-Yutani Health System

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000638

Antiatherogenic drug therapy

antiatherogenic drug therapy: Treatment with a cardiovascular drug that prevents atherogenesis, the accumulation of lipid-containing plaques on the innermost layers of the arteries.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• anti-atherogenic agent therapy
• treatment with anti-atherogenic agent
• treatment with anti-atherogenic drug
• treatment with anti-atherogenic medication
• treatment with anti-atherogenic therapy
• treatment with antiatherogenic agent
• treatment with antiatherogenic drug
• treatment with antiatherogenic medication

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000650 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › cardiovascular agent therapy.

Specialty: Pharmacy

Broader services

• cardiovascular agent therapy

Used to treat

• amyotrophic lateral sclerosis type 4
• rhabdoid tumor predisposition syndrome
• Muggenthaler-Chowdhury-Chioza syndrome
• Leber congenital amaurosis 10
• dilated cardiomyopathy 1C

Showing 5 of 13.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Available at

• Grants Pass Valley Outpatient Center

Providers offering this service

• Dr. Jin Young, MD
• Dr. Fatima Chowdhury, DO
• Dr. Jorge Ahmed, MD
• Dr. Victor Hamilton, MD
• Laura Reed, NP

Showing 5 of 11.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000650

Antibacterial agent therapy

antibacterial agent therapy: Use of a drug to treat or prevent bacterial infections.

As a treatment, antibacterial agent therapy is planned with you. Talk with your care team about benefits, risks and alternatives.

Also known as

• antibacterial treatment
• antibiotic agent therapy
• treatment with an anti-bacterial drug
• treatment with an anti-bacterial medication
• treatment with an anti-bacterial therapy
• treatment with an antibacterial agent
• treatment with an antibacterial drug
• treatment with an antibacterial medication
• treatment with an antibacterial therapy
• treatment with antibacterial drug

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0000061 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › anti-infective agent therapy › antimicrobial agent therapy.

Specialty: Pharmacy

Broader services

• antimicrobial agent therapy

More specific services

• aminoglycoside agent therapy
• macrolide antibacterial agent therapy
• sulfonamide antibacterial agent therapy
• tetracycline therapy

Used to treat

• cardiac tamponade
• disease of mental health
• chronic gonorrhea of cervix
• male breast cancer
• appendix carcinoma

Showing 5 of 8.

Preparing for your visit

Before your visit, confirm your appointment, bring your insurance card and tell staff about any allergies or medications.

Providers offering this service

• Dr. Fatima Chowdhury, DO
• Dr. Darius Brooks, DO
• Dr. Mohammed Novak, MD
• Dr. Fatima Roberts, MD
• Dr. Mei Andersson, DO

Showing 5 of 9.

Related articles

• Is Antibacterial agent therapy Right for You?

Reference links

• http://purl.obolibrary.org/obo/MAXO_0000061

Anticholesteric agent therapy

About this service. Treatment with any agent that lowers cholesterol.

This is a therapeutic service. Your clinician will discuss goals, expected recovery and any follow-up care.

Also known as

• antihypercholesterolemic agent therapy
• cholesterol inhibitor therapy
• hypocholesteremic agent therapy
• treatment with anticholesteremic drug

Classification

Service type: therapeutic.

Ontology identifier: MAXO:0001124 (Medical Action Ontology).

Classification path: therapeutic procedure › pharmacotherapy › cardiovascular agent therapy › dyslipidemic agent therapy.

Specialty: Pharmacy

Broader services

• cardiovascular agent therapy

Used to treat

• cataract 34 multiple types
• ectopia lentis with ectopia of pupil
• compensatory emphysema
• fundus albipunctatus
• calcinosis

Showing 5 of 12.

Preparing for your visit

Your care team will give preparation instructions when you schedule. Call ahead if you have questions or need an interpreter.

Available at

• Portland Westside Clinic

Providers offering this service

• Dr. Olivia Morales, MD
• Dr. Chen Chen, MD
• Dr. Adrian Schmidt, MD
• Dr. Maria Peterson, MD
• Dr. Rachel Alvarez, DO

Showing 5 of 6.

Reference links

• http://purl.obolibrary.org/obo/MAXO_0001124